|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gingold JA, Zhu D, Lee DF, Kaseb A and
Chen J: Genomic profiling and metabolic homeostasis in primary
liver cancers. Trends Mol Med. 24:395–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Youssef AA, Issa HA, Omar MZ, Behiry EG,
Elfallah AA, Hasaneen A, Darwish M and Ibrahim DB: Serum human
endothelial cell-specific molecule-1 (endocan) and vascular
endothelial growth factor in cirrhotic HCV patients with
hepatocellular carcinoma as predictors of mortality. Clin Exp
Gastroenterol. 11:431–438. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Z, Zhang Y, Wang Y, Xu L and Xu W:
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate
biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular
carcinoma. Onco Targets Ther. 9:123–129. 2015.PubMed/NCBI
|
|
5
|
Park SJ, Jang JY, Jeong SW, Cho YK, Lee
SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, et al: Usefulness of
AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing
hepatocellular carcinoma. Medicine (Baltimore). 96:e58112017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Principe M, Borgoni S, Cascione M,
Chattaragada MS, Ferri-Borgogno S, Capello M, Bulfamante S,
Chapelle J, Di Modugno F, Defilippi P, et al: Alpha-enolase (ENO1)
controls alpha v/beta 3 integrin expression and regulates
pancreatic cancer adhesion, invasion, and metastasis. J Hematol
Oncol. 10:162017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Z, Lin B, Pan H, Du J, He R, Zhang S
and Ouyang P: Gene expression profile analysis of ENO1 knockdown in
gastric cancer cell line MGC-803. Oncol Lett. 17:3881–3889.
2019.PubMed/NCBI
|
|
8
|
Sun L, Lu T, Tian K, Zhou D, Yuan J, Wang
X, Zhu Z, Wan D, Yao Y, Zhu X, et al: Alpha-enolase promotes
gastric cancer cell proliferation and metastasis via regulating AKT
signaling pathway. Eur J Pharmacol. 845:8–15. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu W, Li H, Yu Y, Chen J, Chen X, Ren F,
Ren Z and Cui G: Enolase-1 serves as a biomarker of diagnosis and
prognosis in hepatocellular carcinoma patients. Cancer Manag Res.
10:5735–5745. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan P, Wang Y, Zhao S, Liu C, Wang Y, Wen
M, Mao JH, Wei G and Zhang P: FBXW7 negatively regulates ENO1
expression and function in colorectal cancer. Lab Invest.
95:995–1004. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ryans K, Omosun Y, McKeithen DN, Simoneaux
T, Mills CC, Bowen N, Eko FO, Black CM, Igietseme JU and He Q: The
immunoregulatory role of alpha enolase in dendritic cell function
during Chlamydia infection. BMC Immunol. 18:272017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin H, Wang L and Liu HL: ENO1
overexpression in pancreatic cancer patients and its clinical and
diagnostic significance. Gastroenterol Res Pract. 2018:38421982018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu S, Li N, Huang Z, Chen R, Yi P, Kang R,
Tang D, Hu X and Fan X: A novel lncRNA, TCONS_00006195, represses
hepatocellular carcinoma progression by inhibiting enzymatic
activity of ENO1. Cell Death Dis. 9:11842018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun L, Guo C, Cao J, Burnett J, Yang Z,
Ran Y and Sun D: Over-expression of alpha-enolase as a prognostic
biomarker in patients with pancreatic cancer. Int J Med Sci.
14:655–661. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
White-Al Habeeb NM, Di Meo A, Scorilas A,
Rotondo F, Masui O, Seivwright A, Gabril M, Girgis AH, Jewett MA
and Yousef GM: Alpha-enolase is a potential prognostic marker in
clear cell renal cell carcinoma. Clin Exp Metastasis. 32:531–541.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song Y, Luo Q, Long H, Hu Z, Que T, Zhang
X, Li Z, Wang G, Yi L, Liu Z, et al: Correction: Alpha-enolase as a
potential cancer prognostic marker promotes cell growth, migration,
and invasion in glioma. Mol Cancer. 13:2352015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Altenberg B and Greulich KO: Genes of
glycolysis are ubiquitously overexpressed in 24 cancer classes.
Genomics. 84:1014–1020. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Wang H and Dong X: Diagnostic
value of α-enolase expression and serum α-enolase autoantibody
levels in lung cancer. J Bras Pneumol. 44:18–23. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mathivanan S and Simpson RJ: ExoCarta: A
compendium of exosomal proteins and RNA. Proteomics. 9:4997–5000.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mazurek S, Boschek CB, Hugo F and
Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth
and spreading. Semin Cancer Biol. 15:300–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo X, Wei Y, Hai L, Hu Y, Zhao Z, Ma W,
Ma L, Liu X and Ding X: Preliminary study on serum marker α-enolase
of liver cancer in the diagnosis of liver cancer. Chin J Hepatol.
27:505–510. 2019.(In Chinese).
|
|
23
|
Tan HT, Low J, Lim SG and Chung MC: Serum
autoantibodies as biomarkers for early cancer detection. FEBS J.
276:6880–6904. 2009. View Article : Google Scholar : PubMed/NCBI
|
